Redcliffe Labs

pending

IFC is proposing an equity investment of up to US$30 million (INR equivalent) into Redcliffe Lifetech Private Limited (“Redcliffe” or the “Company”), in the form of a Compulsorily Convertible Debentures (CCDs). Redcliffe operates in the fields of precision medicine, routine health check-ups, radiology, genomics, cancer genetic diagnostics, and rare disease testing. Redcliffe operates through the main business entity Redcliffe Lifetech Private Limited and its subsidiary in diagnostics, imaging, services that includes Celara Diagnostics Pvt. Ltd.Redcliffe is present in 220+ cities, having around 76 labs, 1500+ collection centers, 2000+ pickup points and convenient home collection services, reaching people in tier 1, 2 and 3 cities. The Company operates laboratories under a mix of models, including Company Owned and Company Operated (COCO) laboratories, laboratories established within hospital premises under lease or partnership arrangements (hospital-based/leased model) and Franchise Owned and Franchise Operated (FOFO) collection centers.Redcliffe’s operations comprise two phases: Business Development and Diagnostic. The Business Development phase focuses on expanding COCO laboratories, hospital-based/leased labs, and FOFO collection centers. Diagnostic testing is undertaken at COCO laboratories, including hospital-based/leased laboratories, while FOFO centers are limited to sample collection and onward transportation to laboratories and Home Sample collection services. Activities include assessing markets and locations, reviewing property documents and regulatory approvals, evaluating FOFO centers for safety, waste management, and staffing, onboarding OEMs and vendors for equipment and consumables, and centrally managing COCO labs, with FOFO sites run by franchise partners. The Diagnostic phase spans pre-analytical, analytical, and post-analytical stages. Pre-analytical involves sample collection via walk-ins, hospitals, doctors, or home services, with imaging mostly accessed in person; phlebotomists manage interaction, labeling, and documentation before samples reach COCO labs for processing. Analytical work includes quality checks, equipment maintenance, calibration, reagent verification, and external quality assurance to ensure accuracy. Post-analytical activities involve reviewing and validating results, issuing reports through physical or digital channels, and monitoring customer feedback and turnaround time for service quality.Redcliffe Lifetech Pvt. Ltd. is governed by a centralized structure led by the Chief Executive Officer (CEO), supported by a senior leadership team overseeing technology, business and operations, finance, sales, marketing, human resources, and corporate strategy.